DK0517797T3 - Anvendelse af D-vitaminanaloger i behandlingen af akne - Google Patents

Anvendelse af D-vitaminanaloger i behandlingen af akne

Info

Publication number
DK0517797T3
DK0517797T3 DK91905594.7T DK91905594T DK0517797T3 DK 0517797 T3 DK0517797 T3 DK 0517797T3 DK 91905594 T DK91905594 T DK 91905594T DK 0517797 T3 DK0517797 T3 DK 0517797T3
Authority
DK
Denmark
Prior art keywords
pct
vitamin
acne
analogues
treatment
Prior art date
Application number
DK91905594.7T
Other languages
English (en)
Inventor
Wagn Ole Godtfredsen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of DK0517797T3 publication Critical patent/DK0517797T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK91905594.7T 1990-03-01 1991-02-25 Anvendelse af D-vitaminanaloger i behandlingen af akne DK0517797T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909004544A GB9004544D0 (en) 1990-03-01 1990-03-01 Novel treatment ii

Publications (1)

Publication Number Publication Date
DK0517797T3 true DK0517797T3 (da) 1995-11-13

Family

ID=10671792

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91905594.7T DK0517797T3 (da) 1990-03-01 1991-02-25 Anvendelse af D-vitaminanaloger i behandlingen af akne

Country Status (11)

Country Link
US (1) US5292727A (da)
EP (1) EP0517797B1 (da)
JP (1) JPH05504959A (da)
AT (1) ATE127691T1 (da)
AU (1) AU7458891A (da)
DE (1) DE69113029T2 (da)
DK (1) DK0517797T3 (da)
ES (1) ES2079063T3 (da)
GB (1) GB9004544D0 (da)
GR (1) GR3017413T3 (da)
WO (1) WO1991012807A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362719A (en) * 1990-03-01 1994-11-08 Leo Pharmaceutical Products, Ltd. A/S Lovens Kemiske Fabrik Produktionsaktieselskab) Use of vitamin-D analogues in the treatment of acne
US5763426A (en) * 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
PE28297A1 (es) * 1995-01-26 1997-08-20 Hoffmann La Roche Empleo dermatologico de derivados de vitamina d
CA2312060A1 (en) 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin d3 derivatives
CA2312731A1 (en) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin d3 derivatives
US6491936B1 (en) 1997-12-09 2002-12-10 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
EP1178808B2 (en) * 1999-04-23 2019-06-12 Leo Pharma A/S Non-aqueous pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin d, a corticosteroid and a solvent component
TW561047B (en) 1999-08-31 2003-11-11 Chugai Pharmaceutical Co Ltd Soft capsule formulations
CA2425367A1 (en) * 2000-08-30 2003-04-07 Chugai Seiyaku Kabushiki Kaisha Oct formulations
AU2003291810A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
GB0307865D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
US7241752B2 (en) * 2004-11-22 2007-07-10 Wisconsin Alumni Research Foundation 17,20(E)-dehydro vitamin D analogs and their uses
PL2526930T3 (pl) * 2005-06-01 2014-05-30 Glaxosmithkline Ip Dev Ltd Formulacja witaminowa
CA2612408A1 (en) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
JP5869745B2 (ja) 2006-02-03 2016-02-24 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー ２５−ヒドロキシビタミンｄ２及び２５−ヒドロキシビタミンｄ３によるビタミンｄ不足及び欠乏の治療
EP3659608A1 (en) 2006-06-21 2020-06-03 Opko Ireland Global Holdings, Ltd. Therapy using vitamin d repletion agent and vitamin d hormone replacement agent
KR20090039833A (ko) * 2006-08-29 2009-04-22 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US20100273748A1 (en) * 2006-09-08 2010-10-28 The Regents Of The University Of California Antimicrobial therapy
WO2008065514A2 (en) * 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
EP2148685A4 (en) 2007-04-25 2010-07-28 Cytochroma Inc METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
EP3335712A1 (en) 2007-04-25 2018-06-20 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
ES2956794T3 (es) 2007-04-25 2023-12-28 Eirgen Pharma Ltd Liberación controlada de 25-hidroxivitamina D
CN104257667B (zh) 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
US7727562B2 (en) * 2007-06-21 2010-06-01 Blackman Steven T Liquid compositions containing solubilized benzoyl peroxide
CN102046812A (zh) 2008-04-02 2011-05-04 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
KR102125424B1 (ko) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 부갑상선 수준을 낮추기 위한 방법 및 조성물
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
JP2014144929A (ja) * 2013-01-29 2014-08-14 Daiichi Sankyo Healthcare Co Ltd ビタミン類を含有するニキビの予防又は治療用組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
SG10201911274TA (en) 2014-08-07 2020-02-27 Opko Ireland Global Holdings Ltd Adjunctive therapy with 25-hydroxyvitamin d
BR112018069727A2 (pt) 2016-03-28 2019-02-05 Opko Ireland Global Holdings Ltd métodos de tratamento com vitamina d

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
JPS6218A (ja) * 1985-03-14 1987-01-06 Chugai Pharmaceut Co Ltd 皮膚疾患治療用組成物
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
ATE99942T1 (de) * 1989-05-18 1994-01-15 Hoffmann La Roche Dehydrocholecalciferolderivate.

Also Published As

Publication number Publication date
US5292727A (en) 1994-03-08
DE69113029T2 (de) 1996-03-07
JPH05504959A (ja) 1993-07-29
WO1991012807A1 (en) 1991-09-05
EP0517797B1 (en) 1995-09-13
ES2079063T3 (es) 1996-01-01
EP0517797A1 (en) 1992-12-16
AU7458891A (en) 1991-09-18
GB9004544D0 (en) 1990-04-25
ATE127691T1 (de) 1995-09-15
GR3017413T3 (en) 1995-12-31
DE69113029D1 (de) 1995-10-19

Similar Documents

Publication Publication Date Title
DK0517797T3 (da) Anvendelse af D-vitaminanaloger i behandlingen af akne
ES2055845T3 (es) Composicion farmaceutica para el tratamiento de la osteoporosis.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
AU5561686A (en) Method of increasing bone mass
ES2121793T3 (es) Composiciones de uso local para la administracion transdermica de derivados profarmacos de morfina.
ES2193578T3 (es) Complejos de calcio para el enriquecimiento de alimentos.
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
ES2084390T3 (es) Comprimidos de liberacion controlada, de varias capas, que contienen tanto naproxen como sal sodica de naproxen.
FI851686L (fi) Redskap foer anvaendning vid behandling av osteoporosis.
NZ318430A (en) Synergistic combination of VDR ligand(s) and retinoids and their use in the treatment of cell hyperproliferation.
DK1632248T3 (da) Anti-interleukin-9-antistof eller anti-interleukin-9-receptor-antistof til behandling af bronkial overfølsomhed
FI962550A (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
ATE238986T1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
NZ326345A (en) Composition containing diosgenin
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
ES2153689T3 (es) Pastilla de jabon antiseptico.
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
ES2185698T3 (es) Composicion de tratamiento anti-acne de la piel.
NO955347L (no) Hormonelt middel for terapi av akne samt anvendelse derav
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
BR9708511A (pt) Utilização de compostos utilização de ácido 6-[3-(1-adamantil)-4-metoxifenil]-2naftóico e utilização do ácido 6-[3-(1-adamantil)-4-hidroxifenil]-2-naftóico